KR20070068288A - Parenting Composition - Google Patents
Parenting Composition Download PDFInfo
- Publication number
- KR20070068288A KR20070068288A KR1020060133679A KR20060133679A KR20070068288A KR 20070068288 A KR20070068288 A KR 20070068288A KR 1020060133679 A KR1020060133679 A KR 1020060133679A KR 20060133679 A KR20060133679 A KR 20060133679A KR 20070068288 A KR20070068288 A KR 20070068288A
- Authority
- KR
- South Korea
- Prior art keywords
- parenting
- glycol
- hair
- composition
- propylene glycol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 76
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 54
- -1 acetyl pantothenylethylether Chemical compound 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims abstract description 18
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 14
- 229930195729 fatty acid Natural products 0.000 claims abstract description 14
- 239000000194 fatty acid Substances 0.000 claims abstract description 14
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims abstract description 10
- 150000005846 sugar alcohols Polymers 0.000 claims abstract description 10
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims abstract description 9
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 9
- 235000005152 nicotinamide Nutrition 0.000 claims abstract description 9
- 239000011570 nicotinamide Substances 0.000 claims abstract description 9
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 9
- 229940042585 tocopherol acetate Drugs 0.000 claims abstract description 9
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 claims abstract description 8
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 claims abstract description 7
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims abstract description 7
- 239000004615 ingredient Substances 0.000 claims abstract description 7
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229940058015 1,3-butylene glycol Drugs 0.000 claims abstract description 5
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000019437 butane-1,3-diol Nutrition 0.000 claims abstract description 5
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000004480 active ingredient Substances 0.000 claims description 37
- 239000003795 chemical substances by application Substances 0.000 claims description 21
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 16
- 239000002253 acid Substances 0.000 claims description 13
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 claims description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 4
- 229940107588 barberry extract Drugs 0.000 claims description 2
- 230000000384 rearing effect Effects 0.000 claims 1
- 238000010521 absorption reaction Methods 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 13
- 230000003779 hair growth Effects 0.000 abstract description 12
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 230000004936 stimulating effect Effects 0.000 abstract 4
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 abstract 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 abstract 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 abstract 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 abstract 1
- 241000974657 Swertia pseudochinensis Species 0.000 abstract 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 abstract 1
- 229950004864 olamine Drugs 0.000 abstract 1
- 229930007845 β-thujaplicin Natural products 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 52
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 16
- 238000013329 compounding Methods 0.000 description 10
- 210000003491 skin Anatomy 0.000 description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 9
- 235000010855 food raising agent Nutrition 0.000 description 9
- 238000001556 precipitation Methods 0.000 description 9
- 239000003205 fragrance Substances 0.000 description 8
- 238000009792 diffusion process Methods 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 231100000245 skin permeability Toxicity 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 239000003915 liquefied petroleum gas Substances 0.000 description 5
- 229940049964 oleate Drugs 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 4
- 229920002556 Polyethylene Glycol 300 Polymers 0.000 description 4
- 239000003655 absorption accelerator Substances 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 235000021508 Coleus Nutrition 0.000 description 3
- 244000061182 Coleus blumei Species 0.000 description 3
- 235000004866 D-panthenol Nutrition 0.000 description 3
- 239000011703 D-panthenol Substances 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 229910001873 dinitrogen Inorganic materials 0.000 description 3
- LLRANSBEYQZKFY-UHFFFAOYSA-N dodecanoic acid;propane-1,2-diol Chemical compound CC(O)CO.CCCCCCCCCCCC(O)=O LLRANSBEYQZKFY-UHFFFAOYSA-N 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000002834 transmittance Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHHURQMJLARIDK-UHFFFAOYSA-N 2-hydroxypropyl octanoate Chemical compound CCCCCCCC(=O)OCC(C)O GHHURQMJLARIDK-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 240000006766 Cornus mas Species 0.000 description 2
- 235000003363 Cornus mas Nutrition 0.000 description 2
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 2
- OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 229940001890 bittersweet extract Drugs 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 2
- 229940093471 ethyl oleate Drugs 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- FSVSNKCOMJVGLM-UHFFFAOYSA-N octanoic acid;propane-1,2-diol Chemical compound CC(O)CO.CCCCCCCC(O)=O FSVSNKCOMJVGLM-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 229940113115 polyethylene glycol 200 Drugs 0.000 description 2
- 239000002952 polymeric resin Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 230000037307 sensitive skin Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 229920003002 synthetic resin Polymers 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 229940124549 vasodilator Drugs 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- PMUWWDBIGFMHAW-SJORKVTESA-N (2r,3r)-3-hydroxy-3-methyl-2-(4-methylphenyl)-2h-chromen-4-one Chemical compound C1=CC(C)=CC=C1[C@@H]1[C@](O)(C)C(=O)C2=CC=CC=C2O1 PMUWWDBIGFMHAW-SJORKVTESA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- FWNZKPKGBYWNJO-KVVVOXFISA-N (z)-octadec-9-enoic acid;propane-1,2-diol Chemical compound CC(O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O FWNZKPKGBYWNJO-KVVVOXFISA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- VHBSECWYEFJRNV-UHFFFAOYSA-N 2-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1O.OC(=O)C1=CC=CC=C1O VHBSECWYEFJRNV-UHFFFAOYSA-N 0.000 description 1
- FZIPCQLKPTZZIM-UHFFFAOYSA-N 2-oxidanylpropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O FZIPCQLKPTZZIM-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- SUZLHDUTVMZSEV-UHFFFAOYSA-N Deoxycoleonol Natural products C12C(=O)CC(C)(C=C)OC2(C)C(OC(=O)C)C(O)C2C1(C)C(O)CCC2(C)C SUZLHDUTVMZSEV-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 241000047703 Nonion Species 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 244000131415 Zanthoxylum piperitum Species 0.000 description 1
- 235000008853 Zanthoxylum piperitum Nutrition 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 229940124532 absorption promoter Drugs 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- XQGDCUULTKHHEM-UHFFFAOYSA-N butane-1,3-diol Chemical compound CC(O)CCO.CC(O)CCO XQGDCUULTKHHEM-UHFFFAOYSA-N 0.000 description 1
- OVYQSRKFHNKIBM-UHFFFAOYSA-N butanedioic acid Chemical compound OC(=O)CCC(O)=O.OC(=O)CCC(O)=O OVYQSRKFHNKIBM-UHFFFAOYSA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- OHCQJHSOBUTRHG-UHFFFAOYSA-N colforsin Natural products OC12C(=O)CC(C)(C=C)OC1(C)C(OC(=O)C)C(O)C1C2(C)C(O)CCC1(C)C OHCQJHSOBUTRHG-UHFFFAOYSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 210000003022 colostrum Anatomy 0.000 description 1
- 235000021277 colostrum Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- PHMQYKDOTWAOBI-UHFFFAOYSA-N decanoic acid;propane-1,2-diol Chemical compound CC(O)CO.CCCCCCCCCC(O)=O PHMQYKDOTWAOBI-UHFFFAOYSA-N 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- JZGXQKWQIKFIBT-UHFFFAOYSA-N hexadecanoic acid;propane-1,2-diol Chemical compound CC(O)CO.CCCCCCCCCCCCCCCC(O)=O JZGXQKWQIKFIBT-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000001282 iso-butane Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 229960003632 minoxidil Drugs 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- IQUFIVQRGAZYMZ-UHFFFAOYSA-N n-benzyl-7h-purin-6-amine Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CC=C1.N=1C=NC=2N=CNC=2C=1NCC1=CC=CC=C1 IQUFIVQRGAZYMZ-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000001272 nitrous oxide Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 1
- 229940068886 polyethylene glycol 300 Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000003658 preventing hair loss Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- OJTDGPLHRSZIAV-UHFFFAOYSA-N propane-1,2-diol Chemical compound CC(O)CO.CC(O)CO OJTDGPLHRSZIAV-UHFFFAOYSA-N 0.000 description 1
- IUYIRQQAVVYNBK-UHFFFAOYSA-N propane-1,2-diol;tetradecanoic acid Chemical compound CC(O)CO.CCCCCCCCCCCCCC(O)=O IUYIRQQAVVYNBK-UHFFFAOYSA-N 0.000 description 1
- STWNGMSGPBZFMX-UHFFFAOYSA-N pyridine-3-carboxamide Chemical compound NC(=O)C1=CC=CN=C1.NC(=O)C1=CC=CN=C1 STWNGMSGPBZFMX-UHFFFAOYSA-N 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
도 1은 본 발명의 시험에 사용하는 프란츠형 확산 셀의 사시도이다. 1 is a perspective view of a Franz-type diffusion cell used in the test of the present invention.
도 2는 프란츠형 확산 셀을 사용한 시험방법을 설명한 설명도이다. 2 is an explanatory diagram illustrating a test method using a Franz-type diffusion cell.
(부호의 설명)(Explanation of the sign)
1 프란츠형 확산 셀1 Franz diffusion cell
2 도너2 donor
3 리셉터3 receptor
4 교반자4 stirrer
5 등부 박리 피부5 back peeling skin
본 발명은 양육모 유효성분의 경피흡수를 촉진시킴과 동시에, 조성물의 보존안정성이 우수한 양육모제 조성물에 관한 것으로, 보다 상세하게는, 양육모 유효성분의 경피흡수를 향상시킴으로써, 양육모 효과를 보다 유효하게 발휘시키는 양육모제 조성물에 관한 것이다. The present invention relates to a parenting agent composition which promotes percutaneous absorption of the parenting active ingredient and is excellent in storage stability of the composition. More specifically, the parenting effect is more effectively exhibited by improving the percutaneous absorption of the parenting active ingredient. It relates to a parenting composition.
친유성의 양육모 유효성분의 보존안정성을 향상시키는 수단으로서, 제제를 에탄올계로 하는 방법이 일반적이다. 그러나, 에탄올이 많으면, 특히 민감한 피부의 사람에게 있어서는 피부에의 자극감을 느끼거나, 에탄올 냄새를 신경쓰는 사람이 있다. 이 때문에, 에탄올 대신에 물의 함량을 늘리면, 양육모 유효성분의 안정성이 나빠진다고 하는 문제가 있었다. As a means of improving the storage stability of the lipophilic parenting hair active ingredient, the method which uses a formulation as an ethanol is common. However, when there is much ethanol, especially a person with sensitive skin feels irritation to a skin, and there are people who care about an ethanol smell. For this reason, when the content of water is increased instead of ethanol, there is a problem that the stability of the parenting active ingredient is deteriorated.
한편, 표피는 체외로부터의 이물 진입을 저지하는 구조로 되어 있기 때문에, 피부 상에 유효성분을 도포한 것만으로는 표피의 각질층의 배리어 기능에 의해 충분한 경피흡수성이 얻어지지 않는다. 양육모 유효성분의 경우, 그 효과는 피부 내부에의 침투에 의해 발현되므로, 양육모 유효성분의 효과를 증강하기 위해서는, 양육모 유효성분의 피부 투과율을 향상하는 것이 중요하게 된다. 이것에 대하여, 양육모 유효성분의 피부투과율을 개선하기 위해서, 각종 경피흡수 촉진제가 제안되었다. On the other hand, since the epidermis has a structure that prevents foreign substances from entering the body, sufficient transdermal absorption is not obtained by the barrier function of the stratum corneum only by applying an active ingredient on the skin. In the case of the parenting active ingredient, the effect is expressed by penetration into the skin, and in order to enhance the effect of the parenting effective ingredient, it is important to improve the skin permeability of the parenting effective ingredient. On the other hand, in order to improve the skin permeability of the hair raising active ingredient, various transdermal absorption accelerators have been proposed.
상기 경피흡수 촉진제로서, 예를 들면, 계면활성제, 각종 유제, 테르펜류 등이 제안되었다. 구체적으로는, 피부외용제에 있어서의 약제의 침투제로서 분기 지방산 및 알콜(특허문헌 1: 일본 특개평2-207018호 공보 참조)이, 또, 미백 성분의 흡수성 향상을 위해 폴리에틸렌글리콜(특허문헌 2: 일본 특개2001-106621호 공보 참조)이 제안되어 있고, 게다가 육모제의 유효성분인 홀수쇄 지방산 글리세리드의 흡수성 향상을 위해, 짝수 탄소 쇄장 지방산의 모노 또는 디에스테르가 제안되어 있다(특허문헌 3: 일본 특개평4-66516호 공보 참조). 그러나, 이들 흡수촉진제의 대부분은 친유성 물질이며, 육모제 조성물 중에 물이 많이 포함되어 있을 경우, 양육모 유효성분의 석출 등이 나타나, 장기안정성의 확보가 곤란하여, 양육모 유효성 분의 효과를 여전하게 충분히 발휘하는 것에 이르지는 못했다. 이상의 것으로부터, 양육모 유효성분의 경피흡수를 더욱 향상시킴과 동시에, 물의 함유량이 많은 조성물 중에서도, 양육모 유효성분의 석출 등이 억제되어, 조성물의 보존안정성이 우수한 양육모제 조성물이 요망되고 있었다. 또한, 본 발명에 관련되는 선행기술 문헌으로서는 하기를 들 수 있다. As the transdermal absorption accelerators, for example, surfactants, various oil agents, terpenes and the like have been proposed. Specifically, branched fatty acids and alcohols (see Patent Document 1: Japanese Patent Application Laid-Open No. 2-207018) as a penetrating agent of a medicament in an external preparation for skin include polyethylene glycol (Patent Document 2: Japanese Patent Application Laid-Open No. 2001-106621 has been proposed, and mono or diesters of even-carbon long-chain fatty acids have been proposed for improving the water absorption of odd-chain fatty acid glycerides, which are active ingredients of hair growth agents. See G. 4-66516). However, most of these absorption accelerators are lipophilic substances, and when a large amount of water is contained in the hair growth agent composition, precipitation of the parenting active ingredient appears, and it is difficult to secure long-term stability, and the effect of the parenting active ingredient is still sufficiently sufficient. It did not lead to exercise. From the above, while further improving the percutaneous absorption of the parenting hair active ingredient, precipitation of the parenting hair active ingredient, etc. is suppressed in the composition with much water content, and the hair raising agent composition excellent in the storage stability of a composition was desired. Moreover, the following are mentioned as a prior art document concerning this invention.
[특허문헌 1] 일본 특개평2-207018호 공보[Patent Document 1] Japanese Unexamined Patent Publication No. 2-207018
[특허문헌 2] 일본 특개2001-106621호 공보[Patent Document 2] Japanese Patent Application Laid-Open No. 2001-106621
[특허문헌 3] 일본 특개평4-66516호 공보[Patent Document 3] Japanese Unexamined Patent Publication No. 4-66516
[특허문헌 4] 일본 특개평10-72321호 공보[Patent Document 4] Japanese Patent Application Laid-Open No. 10-72321
[특허문헌 5] 일본 특개2003-321330호 공보[Patent Document 5] Japanese Patent Application Laid-Open No. 2003-321330
본 발명은 상기 사정을 감안하여 이루어진 것으로, 두피에 외용함으로써 양육모 유효성분의 경피흡수를 촉진시켜, 모발성장 촉진효과 및 탈모를 예방하는 효과를 가짐과 동시에, 자극이 없고, 에탄올 냄새가 경감되어, 조성물의 수분량이 많아도, 양육모 유효성분의 석출 등이 억제되어 우수한 보존안정성을 갖는 양육모제 조성물을 제공하는 것을 목적으로 한다. The present invention has been made in view of the above circumstances, and by external application to the scalp, it promotes percutaneous absorption of parenting hair active ingredients, has hair growth promoting effect and effect of preventing hair loss, and has no irritation and ethanol odor is reduced, Even if the amount of water in the composition is large, it is an object of the present invention to provide a hair raising composition having excellent storage stability by inhibiting precipitation of the hair raising active ingredient.
본 발명자는, 상기 목적을 달성하기 위해 예의 검토한 결과, 조성 중에 양육모 유효성분과 물을 5∼50질량% 함유하는 양육모제 조성물에, 양육모 유효성분의 경피흡수 촉진제로서, 다가 알콜 및 지방산 프로필렌글리콜에스테르를 배합하면, 양육모 유효성분의 경피흡수가 촉진되고, 또한 수함유량이 많은 조성임에도 불구하고, 양육모 유효성분의 저온에서의 석출을 억제할 수 있는 것을 발견하고, 본 발명을 완성하게 되었다. MEANS TO SOLVE THE PROBLEM As a result of earnestly examining in order to achieve the said objective, the polyhydric alcohol and fatty acid propylene glycol ester as a percutaneous absorption promoter of a parenting hair active ingredient in the parenting composition containing 5-50 mass% of parenting hair active ingredients and water in a composition. When the compound was formulated, it was found that the percutaneous absorption of the parenting active ingredient is promoted, and that the precipitation of the parenting active ingredient at low temperature can be suppressed despite the composition having a large water content, thereby completing the present invention.
따라서, 본 발명은 하기 발명을 제공한다. Accordingly, the present invention provides the following invention.
[1]. (A)양육모 유효성분, (B)다가 알콜, (C)지방산 프로필렌글리콜에스테르 및 (D)물 5∼50질량%를 함유하는 양육모제 조성물. [One]. A parenting composition containing (A) parenting hair active ingredient, (B) polyhydric alcohol, (C) fatty acid propylene glycol ester, and (D) 5-50 mass% of water.
[2]. 또한, (E)폴리옥시에틸렌올레일에테르를 포함하는 [1] 기재의 양육모제 조성물. [2]. Furthermore, the parenting agent composition as described in [1] containing (E) polyoxyethylene oleyl ether.
[3]. (A)양육모 유효성분이 아세트산 토코페롤, 니코틴산 아미드, 판토테닐알콜, 아세틸판토테닐에틸에테르, 히노키티올, 자주쓴풀 추출액, β-글리시레틴산, 1-멘톨, 피로크톤올라민 및 이소프로필메틸페놀로부터 선택되는 1종 또는 2종 이상인 [1] 또는 [2] 기재의 양육모제 조성물. [3]. (A) Parenting active ingredient is selected from tocopherol acetate, nicotinic acid amide, pantothenyl alcohol, acetylpantotenylethyl ether, hinokithiol, bittersweet extract, β-glyciletin acid, 1-menthol, pyroctonolamine and isopropylmethylphenol The raising agent composition as described in [1] or [2] which is 1 type, or 2 or more types.
[4]. (B)다가 알콜이 폴리에틸렌글리콜, 프로필렌글리콜, 디프로필렌글리콜, 1,3-부틸렌글리콜 및 이소프렌글리콜로부터 선택되는 1종 또는 2종 이상인 [1]∼[3]중 어느 하나에 기재된 양육모제 조성물. [4]. (B) The parenting agent composition according to any one of [1] to [3], wherein the polyhydric alcohol is one or two or more selected from polyethylene glycol, propylene glycol, dipropylene glycol, 1,3-butylene glycol, and isoprene glycol. .
(발명을 실시하기 위한 최량의 형태)(The best form to carry out invention)
본 발명의 (A)성분은 양육모 유효성분이다. 양육모 유효성분으로서는, 세포 부활(賦活)제, 비타민류, 호르몬류, 혈관확장제, 아미노산류, 항염증제, 살균제, 각질용해제 등을 들 수 있고, 1 종 단독으로 또는 2종 이상을 적당하게 조합하여 사용할 수 있다. 구체적으로는, 세포 부활제로서는, 펜타데칸산 글리세리드, 히노 키티올, 포르스콜린, 트랜스-3,4'-디메틸-3-히드록시플라바논 등, 비타민류로서는 아세트산 토코페롤 등의 토코페롤류, 니코틴산, 니코틴산 아미드, 팔미트산 레티놀, β-카로틴, 칼시페롤, 폴산, 비오틴, D-판토테닐알콜, 아세틸판토테닐에틸에테르, 판토텐산 칼슘, 판토테닐에틸에테르, 아스코르브산, 호르몬류로서는, 에스트라디올 등, 혈관확장제로서는, 미녹시딜, 자주쓴풀 추출액 등, 아미노산류로서는, 아르기닌, 아스파르트산, 메티오닌, 세린, 글리신, 글루탐산, 시스틴 등, 항염증제로서는, β-글리시레틴산, 글리시리즈산류, 염산피리독신 등, 살균제로서는, 이소프로필메틸페놀, 피로크톤올라민 등을 들 수 있다. 유효성분으로서는, 아세트산 토코페롤, 니코틴산 아미드, 판토테닐알콜, 아세틸판토테닐에틸에테르, 히노키티올, 자주쓴풀 추출액, β-글리시레틴산, 1-멘솔, 피로크톤올라민 및 이소프로필메틸페놀이 바람직하다. (A) component of this invention is a parenting hair effective ingredient. Examples of parenting hair active ingredients include cell activators, vitamins, hormones, vasodilators, amino acids, anti-inflammatory agents, fungicides, and keratin-soluble agents, and can be used alone or in combination of two or more. Can be. Specifically, examples of the cell activator include pentadecanoic acid glycerides, hino chitinol, forskolin, trans-3,4'-dimethyl-3-hydroxyflavanone, and vitamins such as tocopherols such as tocopherol acetate and nicotinic acid. Examples of nicotinic acid amide, palmitic retinol, β-carotene, calciferol, folic acid, biotin, D-pantothenyl alcohol, acetylpantotenylethyl ether, calcium pantothenate, pantothenylethyl ether, ascorbic acid, and hormones include estradiol As vasodilators, such as minoxidil, bitter grass extract, amino acids, such as arginine, aspartic acid, methionine, serine, glycine, glutamic acid, cystine, and the like, as anti-inflammatory agents, β-glyciretinic acid, glycyric acid, pyridoxine hydrochloride, etc. As an isopropyl methyl phenol, a pyroctonolamine etc. are mentioned. As the active ingredient, tocopherol acetate, nicotinic acid amide, pantothenyl alcohol, acetylpantotenylethyl ether, hinokithiol, bittersweet extract, β-glyciletinic acid, 1-menthol, pyroctonolamine and isopropylmethylphenol are preferable.
(A)양육모 유효성분의 배합량은, 배합하는 양육모 유효성분의 유효량이지만, 통상, 양육모제 조성물 중 0.001∼10질량%이며, 0.005∼5질량%가 바람직하다. (A) Although the compounding quantity of the raising parent active ingredient is an effective amount of the raising parent active ingredient mix | blended, it is normally 0.001-10 mass% in a raising agent composition, and 0.005-5 mass% is preferable.
(B)성분은 다가 알콜이며, 1종 단독으로 또는 2종 이상을 적당하게 조합하여 사용할 수 있다. 에틸렌글리콜, 디에틸렌글리콜, 트리에틸렌글리콜, 폴리에틸렌글리콜, 프로필렌글리콜, 디프로필렌글리콜, 폴리프로필렌글리콜, 1,3-부틸렌글리콜, 이소프렌글리콜 등을 들 수 있다. 이 중에서도, 폴리에틸렌글리콜, 프로필렌글리콜, 디프로필렌글리콜, 1,3-부틸렌글리콜, 이소프렌글리콜이 바람직하고, 특히 폴리에틸렌글리콜이 바람직하다. (B) component is polyhydric alcohol, and can be used individually by 1 type or in combination of 2 or more types. Ethylene glycol, diethylene glycol, triethylene glycol, polyethylene glycol, propylene glycol, dipropylene glycol, polypropylene glycol, 1, 3- butylene glycol, isoprene glycol, etc. are mentioned. Among these, polyethylene glycol, propylene glycol, dipropylene glycol, 1,3-butylene glycol and isoprene glycol are preferable, and polyethylene glycol is especially preferable.
폴리에틸렌글리콜의 바람직한 평균분자량(화장품원료기준에 수록된 폴리에틸 렌글리콜 200의 평균분자량 시험법을 준용)의 범위는, 200∼1000, 보다 바람직하게는200∼400이다. 구체적으로는, 폴리에틸렌글리콜 200, 300, 400, 600, 1000(이상 화장품원료기준 준거)이 바람직하고, 보다 바람직하게는 폴리에틸렌글리콜 300∼600이다. 이 범위에서 양육모 유효성분의 경피흡수 촉진이 보다 향상된다. The range of the preferable average molecular weight of polyethyleneglycol (the average molecular weight test method of polyethylene glycol 200 listed in cosmetic raw material standard) is 200-1000, More preferably, it is 200-400. Specifically, polyethylene glycol 200, 300, 400, 600, 1000 (based on cosmetic raw material standards) are preferable, More preferably, they are 300-600 polyethylene glycol. In this range, the percutaneous absorption promotion of the parenting active ingredient is further improved.
(B)다가 알콜의 배합량은 적당하게 조정할 수 있지만, 양육모제 조성물 중 0.001∼20질량%가 바람직하고, 보다 바람직하게는 0.01∼10질량%이다. 지나치게 적으면 만족스런 경피흡수 촉진 효과가 발휘되지 않을 경우가 있고, 20질량%를 초과하여 배합해도, 통상 그 이상의 효과 향상은 발휘되지 않는다. (B) Although the compounding quantity of polyhydric alcohol can be adjusted suitably, 0.001-20 mass% is preferable in a hair raising agent composition, More preferably, it is 0.01-10 mass%. When too small, satisfactory transdermal absorption promoting effect may not be exhibited, and even if it mixes more than 20 mass%, the further effect improvement is not exhibited normally.
본 발명의 (C)성분은 지방산 프로필렌글리콜에스테르이며, 1종 단독으로 또는 2종 이상을 적당하게 조합하여 사용할 수 있다. 지방산 프로필렌글리콜 에스테르를 구성하고 있는 지방산으로서는 포화 지방산이어도 불포화 지방산이어도 된다. 또, 불포화 지방산은 1개 또는 복수의 이중결합을 함유하고 있어도 된다. 탄소쇄의 탄소수는, 바람직하게는 6∼22, 보다 바람직하게는 8∼18이며, 탄소쇄는 직쇄상이어도 분기쇄상이어도 된다. 이러한 지방산 프로필렌글리콜로서는, 옥탄산 프로필렌글리콜, 데칸산 프로필렌글리콜, 라우르산 프로필렌글리콜, 미리스트산 프로필렌글리콜, 팔미트산 프로필렌글리콜, 올레산 프로필렌글리콜, 스테아르산 프로필렌글리콜 등을 들 수 있고, 올레산 프로필렌글리콜, 라우르산 프로필렌글리콜이 특히 바람직하다. (C) component of this invention is fatty acid propylene glycol ester, It can be used individually by 1 type or in combination of 2 or more types. The fatty acid constituting the fatty acid propylene glycol ester may be a saturated fatty acid or an unsaturated fatty acid. In addition, the unsaturated fatty acid may contain one or a plurality of double bonds. The carbon number of the carbon chain is preferably 6 to 22, more preferably 8 to 18, and the carbon chain may be linear or branched. Examples of such fatty acid propylene glycol include propylene glycol octanoate, propylene glycol decanoate, propylene glycol laurate, propylene glycol myristic acid, propylene glycol palmitic acid, propylene glycol oleate, and propylene glycol stearate. Glycol and propylene glycol laurate are particularly preferred.
(C)지방산 프로필렌글리콜 에스테르의 배합량은 적당히 조제할 수 있지만, 양육모제 조성물 중 0.01∼20질량%가 바람직하고, 보다 바람직하게는 0.1∼10질량% 이다. 지나치게 적으면 만족스런 경피흡수 촉진 효과가 발휘되지 않을 경우가 있고, 20질량%를 초과하여 배합해도, 통상 그것 이상의 효과 향상은 발휘되지 않는다. Although the compounding quantity of (C) fatty acid propylene glycol ester can be prepared suitably, 0.01-20 mass% is preferable in a hair raising agent composition, More preferably, it is 0.1-10 mass%. When too small, satisfactory transdermal absorption promoting effect may not be exhibited, and even if it mixes more than 20 mass%, the effect improvement beyond that is not normally exhibited.
(B)다가 알콜과, (C)지방산 프로필렌글리콜 에스테르와의 배합 질량비((B)/(C))는 1/10∼100/1이 바람직하고, 보다 바람직하게는 1/5∼10/1이다. 이 비율로 함으로써, 양육모 유효성분의 경피흡수 촉진이 보다 향상된다. As for the compounding mass ratio ((B) / (C)) of (B) polyhydric alcohol and (C) fatty acid propylene glycol ester, 1/10-100/1 are preferable, More preferably, 1/5-10/1 to be. By setting it as this ratio, the percutaneous absorption promotion of the hair raising active ingredient improves more.
본 발명의 (D)성분은 물이며, 그 배합량은 양육모제 조성물 중 5∼50질량%이다. 이 범위의 물의 배합량이어도, 양육모 유효성분의 저온에서의 석출을 억제할 수 있어, 보존안정성이 우수하다. 또한, 물의 배합량이 양육모제 조성물 중 10∼50질량%, 특히 15∼40질량%의 범위에 있어서도, 보다 효과를 발휘할 수 있다. (D) component of this invention is water, and the compounding quantity is 5-50 mass% in the hair raising composition. Even if it is the compounding quantity of water of this range, precipitation of the hair raising active ingredient at low temperature can be suppressed and it is excellent in storage stability. Moreover, even if the compounding quantity of water is in the range of 10-50 mass%, especially 15-40 mass% in a hair raising composition, it can exhibit more effects.
본 발명의 양육모제 조성물에는, (E)폴리옥시에틸렌올레일에테르를 더 배합하면 된다. (E)폴리옥시에틸렌올레일에테르는 1종 단독으로 또는 2종 이상을 적당하게 조합하여 사용할 수 있다. 폴리옥시에틸렌올레일에테르의 평균 EO 부가 몰수는, 바람직하게는 1∼20, 보다 바람직하게는 1∼10, 더욱 바람직하게는 1∼5이다. What is necessary is just to mix | blend (E) polyoxyethylene oleyl ether with the hair raising agent composition of this invention. (E) Polyoxyethylene oleyl ether can be used individually by 1 type or in combination of 2 or more types. The average EO addition mole number of polyoxyethylene oleyl ether becomes like this. Preferably it is 1-20, More preferably, it is 1-10, More preferably, it is 1-5.
(E)폴리옥시에틸렌올레일에테르의 배합량은 양육모제 조성물 중 0.01∼10질량%가 바람직하고, 보다 바람직하게는 0.05∼5질량%이다. 배합량이 지나치게 적으면 만족스런 경피흡수 촉진 효과가 발휘되지 않을 경우가 있고, 또, 10질량%를 초과하여 배합해도, 통상 그것 이상의 효과 향상은 발휘되지 않고, 끈적거림 등 사용감을 저하시키는 경우가 있다. As for the compounding quantity of (E) polyoxyethylene oleyl ether, 0.01-10 mass% is preferable in a hair raising composition, More preferably, it is 0.05-5 mass%. If the blending amount is too small, satisfactory transdermal absorption promoting effect may not be exhibited, and even if blended in excess of 10% by mass, the effect improvement beyond that is not usually exhibited, and the usability such as stickiness may be reduced. .
본 발명의 양육모제 조성물에는 에탄올을 배합할 수 있고, 그 자극 냄새 억 제의 점에서, 발효 에탄올이 바람직하다. 에탄올의 양육모제 조성물 중에서의 배합량의 하한은 40질량%가 바람직하고, 보다 바람직하게는 50질량%이고, 배합량의 상한은 90질량%가 바람직하고, 보다 바람직하게는 80질량%이고, 더욱 바람직하게는 70질량%이다. Ethanol can be mix | blended with the hair raising composition of this invention, and fermentation ethanol is preferable at the point of suppressing the irritating smell. 40 mass% is preferable, and, as for the minimum of the compounding quantity in the hair raising composition of ethanol, the upper limit of a compounding quantity is preferable, 90 mass% is preferable, More preferably, it is 80 mass%, More preferably, Is 70 mass%.
양육모제 조성물에는, 상기 필수 성분 이외에, 그 사용목적 등에 따라, 본 발명의 효과를 손상하지 않는 범위에서, 임의 성분을 배합할 수 있다. 그러한 임의 성분으로서는, 예를 들면, 에탄올 이외의 알콜, 비이온성 계면활성제, 당질계 계면활성제, 그 밖의 계면활성제, 셀룰로오스류, 유지류, 고분자 수지, 색제, 향료, 자외선 흡수제 및 각질 용해제 등을 들 수 있고, 1종 단독으로 또는 2종 이상을 적당하게 조합하여 사용할 수 있다. In addition to the essential components described above, the parenting agent composition may be blended with any component within the range not impairing the effects of the present invention depending on the purpose of use and the like. Examples of such optional components include alcohols other than ethanol, nonionic surfactants, saccharide surfactants, other surfactants, celluloses, fats and oils, polymer resins, colorants, flavoring agents, ultraviolet absorbers, and keratin solubilizers. It can be used individually by 1 type or in combination of 2 or more types.
계면활성제로서는, 폴리옥시에틸렌 경화 피마자유, 폴리옥시에틸렌 경화 피마자유 모노 또는 이소스테아레이트, 글리세린 지방산 에스테르 등, 셀룰로오스류로서는, 히드록시메틸셀룰로오스, 히드록시프로필셀룰로오스, 히드록시프로필메틸셀룰로오스 등, 유지류로서는, 홍화유, 월견초유, 호호바유 등, 고분자 수지로서는, 양쪽성, 양이온성, 음이온성 및 비이온성 폴리머 등, 자외선 흡수제로서는, 메톡시신남산 옥틸(네오헤리오판 AV; Haamann & Reimer사 상품명), 옥시벤존, 우로칸산 등, 각질용해제로서는 살리실산, 레조르신 등을 들 수 있다. As surfactant, as celluloses, such as polyoxyethylene hardened castor oil, polyoxyethylene hardened castor oil mono or isostearate, glycerin fatty acid ester, hydroxymethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, etc. Examples of the polymer resins such as safflower oil, moonshine colostrum oil and jojoba oil include, for example, amphoteric, cationic, anionic and nonionic polymers such as ultraviolet absorbents such as octyl oxycinnamate (neoheliopan AV; Haamann & Reimer trade name), Examples of keratin solubilizers such as oxybenzone and uronic acid include salicylic acid and resorcin.
본 발명의 양육모제 조성물에 향료를 배합하는 경우, 사용되는 향료는, 일본 특개2003-95895호 공보에 기재한 향료, 향료 조성물에 준하고, 향료 조성물을 배합하는 경우, 양육모제 조성물 전량에 대해, 향료 조성물이 0.00001∼50질량%가 되도 록 배합하면 바람직하고, 보다 바람직하게는 0.0001∼30질량%이다. When mix | blending a fragrance with the raising agent composition of this invention, the fragrance used is based on the fragrance and fragrance composition of Unexamined-Japanese-Patent No. 2003-95895, and when mix | blending a fragrance composition, with respect to the whole raising agent composition whole quantity, It is preferable to mix | blend so that a fragrance composition may be 0.00001-50 mass%, More preferably, it is 0.0001-30 mass%.
본 발명의 양육모제 조성물은 상법에 따라 조제할 수 있고, 균일 용액, 로션, 젤 등의 형태로 조제할 수 있다. 또, 본 발명의 양육모제 조성물은, 에어로졸의 형태를 취할 수 있고, 그 경우에는, 상기의 성분 이외에, n-프로필알콜, 이소프로필알콜 등의 저급 알콜, 부탄, 프로판, 이소부탄, 액화 석유가스, 디메틸에테르 등의 가연성 가스, 질소 가스, 산소 가스, 탄산 가스, 아산화질소 가스 등의 압축가스를 배합할 수 있고, 이것들의 혼합물의 사용도 가능하다. 그 경우, 디메틸에테르와 질소 가스를 질량비(디메틸에테르/질소 가스)=99.99/0.01∼50/50로 배합, 액화 석유가스와 디메틸에테르를 질량비(액화 석유가스/디메틸에테르)=99/1∼1/99로 배합, 액화 석유가스와 질소를 질량비(액화 석유가스/질소)=99.99/0.01∼50/50로 배합하는 것이 바람직하다. The parenting agent composition of this invention can be prepared according to a conventional method, and can be prepared in the form of a uniform solution, lotion, a gel, etc. Moreover, the hair raising composition of this invention can take the form of an aerosol, and in that case, in addition to the said component, lower alcohols, such as n-propyl alcohol and isopropyl alcohol, butane, propane, isobutane, liquefied petroleum gas Compressed gases, such as flammable gases, such as dimethyl ether, nitrogen gas, oxygen gas, carbon dioxide gas, and nitrous oxide gas, can be mix | blended, and the mixture of these can also be used. In that case, dimethyl ether and nitrogen gas are mixed at a mass ratio (dimethyl ether / nitrogen gas) = 99.99 / 0.01 to 50/50, and liquefied petroleum gas and dimethyl ether are mass ratio (liquefied petroleum gas / dimethyl ether) = 99/1 to 1 It is preferable to mix | blend / 99 and liquefied petroleum gas and nitrogen in mass ratio (liquefied petroleum gas / nitrogen) = 99.99 / 0.01-50 / 50.
본 발명의 양육모제 조성물은, 양육모 유효성분의 두피에의 경피흡수 촉진 효과를 가지므로, 우수한 양육모 효과를 발휘함과 동시에, 장시간에 걸쳐 양육모 유효성분이 안정한 실용성이 높은 것이며, 상기 (A) 및 (D) 성분을 함유하는 혼합물에, (B), (C), 바람직하게는 (E) 성분을 배합하여 이루어지는 혼합물로 이루어지는 양육모 유효성분의 경피흡수 촉진제로서 유용하다. 또한, 물을 5∼50질량% 함유하므로, 민감 피부용으로서도 적합하며, 에탄올 냄새를 저감할 수 있다. Since the parenting agent composition of the present invention has a percutaneous absorption promoting effect on the scalp of the parenting active ingredient, it exhibits excellent parenting effect, and has high practicality in which the parenting active ingredient is stable for a long time, and the above (A) and ( It is useful as a percutaneous absorption accelerator of the hair raising active ingredient which consists of a mixture which mix | blends (B), (C), Preferably (E) component with the mixture containing D) component. Moreover, since it contains 5-50 mass% of water, it is suitable also for sensitive skin and can reduce an ethanol odor.
(실시예)(Example)
이하, 실시예 및 비교예를 제시하여, 본 발명을 구체적으로 설명하지만, 본 발명은 하기의 실시예에 제한되는 것은 아니다. 또한, 하기의 예에서 특별히 명기 가 없는 경우에는, 조성의 「%」는 질량%를 나타낸다. Hereinafter, although an Example and a comparative example are shown and this invention is demonstrated concretely, this invention is not limited to the following Example. In addition, in the following example, when there is no specification in particular, "%" of a composition shows the mass%.
[실시예 1∼11, 비교예 1∼5」Examples 1 to 11 and Comparative Examples 1 to 5
표 1∼3에 나타내는 조성의 양육모제 조성물을 조제하고, 양육모제 조성물 중의 양육모 유효성분의 피부투과율과, 양육모제 조성물의 저온안정성을 평가했다. 결과를 표 1∼3에 병기한다. The parenting agent composition of the composition shown to Tables 1-3 was prepared, and the skin transmittance of the parenting active ingredient in the parenting agent composition, and the low temperature stability of the parenting agent composition were evaluated. The results are written together in Tables 1-3.
<양육모 유효성분의 피부투과율><Skin Permeability of Parenting Active Ingredients>
피부투과율을 도 1에 도시하는, 유리제의 프란츠형 확산 셀을 사용하여 측정했다. 프란츠형 확산 셀을 사용한 유효성분의 피부투과율 측정방법을 도 1, 2를 사용하여 설명한다. Skin permeability was measured using the glass Franz type diffusion cell shown in FIG. The skin transmittance measuring method of the active ingredient using Franz type diffusion cell is demonstrated using FIGS.
미리 털을 깎은 모르모트(HARTLEY계, 암컷)의 등부 박리피부(5)(5cm×5cm)를 프란츠형 확산 셀(1)(확산 유효막 면적 약 4cm2)에, 각질층측이 도너(2)상, 진피측이 리셉터(3)상이 되도록 끼우고 고정했다. 리셉터(3)측을 생리 식염수로 채운 후, 교반자(4)로 교반하면서 항온층에서 32℃로 보온했다. 도너(2)(각질층측)에 피검시료 50μL를 첨가하고, 첨가 24시간 후에 리셉터(3) 내의 생리 식염수를 샘플링했다. 생리적 식염수 중의 양육모 유효성분을 정량하고, 리셉터(3)상 중의 상기 유효성분량(피부투과량)을 측정했다. The exfoliated skin 5 (5 cm x 5 cm) of a mortar (HARTLEY type, female) previously shaved off is placed in the Franz-type diffusion cell 1 (diffusion effective film area approximately 4 cm 2 ), and the stratum corneum layer is on the donor (2). It was inserted and fixed so that the dermal side was on the receptor (3). After the
각 유효성분의 2%에탄올 용액(콘트롤)의 투과량을 투과율 100%로 했을 때의, 각 조성물의 투과량의 상대값(%)을 산출했다. The relative value (%) of the permeation amount of each composition when the permeation amount of the 2% ethanol solution (control) of each active ingredient was made into 100% of the transmittance | permeability was computed.
양육모 유효성분의 정량법에 대해, 하기에 나타낸다. About the quantification method of the hair raising active ingredient, it shows below.
(1) 아세트산 토코페롤 (1) tocopherol acetate
일본약국방 해설서 아세트산 토코페롤 정량법에 기초하여 측정했다. It measured based on the Japanese Pharmacopoeia Commentary, Tocopherol Acetate Assay.
(2) 니코틴산 아미드 고속 액체크로마토그래피(HPLC)를 사용하여 정량했다. (2) Nicotinic acid amide Quantification was carried out using high performance liquid chromatography (HPLC).
검출기: 자외흡광광도계(측정 파장: 210∼270nm)Detector: ultraviolet absorbance photometer (wavelength: 210-270 nm)
컬럼: Inertsil ODS-2(φ4.6×150mm, 지엘사이언스사제)Column: Inertsil ODS-2 (φ4.6 × 150mm, manufactured by GLS Sciences)
이동상: 메탄올/물 혼합액 Mobile phase: methanol / water mixture
<저온안정성 평가><Low Temperature Stability Evaluation>
피검시료 50mL를 캡 부착 투명 유리병에 충전한 후,-5℃로 보존했을 때의 석출·침전의 유무를 외관으로 평가했다. 외관을 관찰하고, 이하의 기준으로 저온안정성을 평가했다. After filling 50 mL of the test sample in the transparent glass bottle with a cap, the presence or absence of precipitation and precipitation at the time of storing at -5 degreeC was evaluated externally. The external appearance was observed and low temperature stability was evaluated on the following references | standards.
기준standard
석출·침전물이 확인되기까지 걸린 일수Number of days before precipitation or sediment was confirmed
1주 미만: ×<1 week: ×
1주 이상∼2주 미만: △1 to 2 weeks: △
2주 이후에도 석출·침전이 확인되지 않음: ○Precipitation and sedimentation have not been confirmed after 2 weeks: ○
본 발명의 양육모제 조성물(실시예 1∼11)은, 모두 피부투과량에 있어서 우수한 특성을 나타내고 있는 것에 반해, 본 발명의 범위밖의 양육모제 조성물(비교예 1∼5)은 모두 우수한 특성을 나타내지 않았다. While all of the parenting agent compositions (Examples 1 to 11) of the present invention exhibited excellent properties in skin penetration, all of the parenting agent compositions (Comparative Examples 1 to 5) outside the scope of the present invention did not exhibit excellent characteristics. .
이하, 양육모제 조성물의 실시예를 나타낸다. 또한, 하기의 각 실시예의 양육모제 조성물은 각각의 조성에 따라서 각 제형의 상법에 준하여 조제했다. Hereinafter, the Example of the hair raising agent composition is shown. In addition, the hair raising composition of each following example was prepared according to the conventional method of each formulation according to each composition.
[실시예 12]Example 12
(육모 로션)(Hair growth lotion)
조성 %Furtherance %
D-판토테닐알콜 2.0D-pantothenyl alcohol 2.0
니코틴산 아미드 1.0Nicotinic Acid Amide 1.0
6-벤질아미노푸린 1.06-benzylaminopurine 1.0
β-글리시레틴산 0.5β-glyciletic acid 0.5
이소프로필메틸페놀 0.5Isopropylmethylphenol 0.5
피로크톤올라민 0.1Pyroctonolamine 0.1
자주쓴풀 엑스 0.1Frequent X 0.1
프로필렌글리콜 5.0Propylene Glycol 5.0
PEG 300 1.0PEG 300 1.0
올레산 프로필렌글리콜 0.5Propylene Glycol Oleate 0.5
모노옥탄산 프로필렌글리콜 0.5Monooctanoic Acid Propylene Glycol 0.5
POE(2) 올레일에테르 0.5POE (2) Oleyl Ether 0.5
POE(30) 테트라올레산 소르비트 0.05POE (30) tetraoleic acid sorbet 0.05
1-멘톨(합성) 0.11-menthol (synthetic) 0.1
히노키티올 0.3Hinokithiol 0.3
메틸파라벤 0.1Methylparaben 0.1
시트르산 0.05Citric Acid 0.05
향료* 0.3Spices * 0.3
정제수 20.0Purified water 20.0
99% 에탄올 잔부 99% ethanol balance
합계 100.0Total 100.0
* 일본 특개2003-113019호 공보 기재의 표2B 조성을 사용했다. * The composition of Table 2B of Japanese Patent Laid-Open No. 2003-113019 was used.
[실시예 13]Example 13
(육모 헤어 스프레이)(Hair growth hair spray)
조성 %Furtherance %
(원액)(Stock)
판토테닐에틸에테르 1.0Pantothenylethyl Ether 1.0
살리실산 0.5Salicylic Acid 0.5
피로크톤올라민 0.1Pyroctonolamine 0.1
니코틴산 아미드 0.05Nicotinic Acid Amide 0.05
β-글리시레틴산 0.05β-glycitinic acid 0.05
6-벤질아미노푸린 1.06-benzylaminopurine 1.0
PEG 300 3.0PEG 300 3.0
올레산 프로필렌글리콜 0.5Propylene Glycol Oleate 0.5
POE(2) 올레일에테르 0.1POE (2) Oleyl Ether 0.1
POE(40) 경화 피마자유 0.5POE (40) Cured Castor Oil 0.5
연명초 추출액 1.0Yeonmyeongcho Extract 1.0
시트르산 0.1Citric Acid 0.1
1-멘톨(합성) 0.51-menthol (synthetic) 0.5
향료* 적당량Fragrance *
정제수 30.0Purified water 30.0
99% 에탄올 잔부 99% ethanol balance
합계 100.0Total 100.0
(희석용 충전액)(Diluent)
상기 원액 75The stock solution 75
디메틸에테르 25Dimethyl ether 25
질소 적당량 Nitrogen
합계 100.0Total 100.0
제품 내압: 0.6MPa(25℃)Product pressure: 0.6 MPa (25 ℃)
*일본 특개2003-113019호 공보 기재의 표 2D 조성을 사용했다. * Table 2D composition of Unexamined-Japanese-Patent No. 2003-113019 was used.
[실시예 14]Example 14
(육모 토닉)(Hair growth tonic)
조성 %Furtherance %
아세트산 토코페롤 0.1Tocopherol Acetate 0.1
β-글리시레틴산 0.1β-glycitinic acid 0.1
니코틴산 아미드 0.1Nicotinic Acid Amide 0.1
6-벤질아미노푸린 1.06-benzylaminopurine 1.0
이소프로필메틸페놀 0.1Isopropylmethylphenol 0.1
PEG 300 1.0PEG 300 1.0
POE(2) 올레일에테르 0.1POE (2) Oleyl Ether 0.1
올레산 프로필렌글리콜 1.0Oleic Acid Propylene Glycol 1.0
콜레우스·폴스콜리뿌리 추출물 0.5Coleus Paul's Coli Root Extract 0.5
숙신산 0.1Succinic Acid 0.1
향료* 0.5Fragrance * 0.5
정제수 35.0Purified water 35.0
95% 에탄올 잔부 95% ethanol balance
합계 100.0Total 100.0
* 일본 특개2003-113019 기재 표 2의 A 조성을 사용* A composition of Table 2 of Japanese Patent Laid-Open No. 2003-113019 is used.
상기 실시예 12∼14의 각종 제형의 양육모제 조성물에 대해 상기 실시예와 동일하게 양육모 성분의 피부투과율을 평가한 바, 모두 높은 양육모 성분의 피부투과율을 나타냈다. The skin permeability of the hair raising component was evaluated in the same manner as in the above example with respect to the hair raising composition of the various formulations of Examples 12 to 14, and all showed high skin permeability of the hair raising component.
상기 예에서 사용한 원료를 나타낸다. The raw material used by the said example is shown.
본 발명의 양육모제 조성물은, (A)양육모 유효성분 및 (D)물 5∼50질량%를 함유하는 양육모제 조성물에, (B)다가 알콜 및 (C)지방산 프로필렌글리콜에스테르를 배합함으로써 양육모 유효성분의 경피흡수를 촉진시켜, 우수한 양육모 효과를 발휘할 수 있고, 도한 보존안정성의 향상을 도모할 수 있다. The parenting agent composition of this invention is effective in raising hair growth by mix | blending (B) polyhydric alcohol and (C) fatty acid propylene glycol ester with the parenting agent composition containing (A) the raising parent active ingredient and (D) 5-50 mass% of water. The percutaneous absorption of the components can be promoted, and the excellent hair growth effect can be exhibited, and the storage stability can be improved.
Claims (4)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005371491A JP2007169233A (en) | 2005-12-26 | 2005-12-26 | Hair nourishing composition |
| JPJP-P-2005-00371491 | 2005-12-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20070068288A true KR20070068288A (en) | 2007-06-29 |
Family
ID=38296275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020060133679A Withdrawn KR20070068288A (en) | 2005-12-26 | 2006-12-26 | Parenting Composition |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP2007169233A (en) |
| KR (1) | KR20070068288A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20160021427A (en) * | 2013-05-15 | 2016-02-25 | 라이온 가부시키가이샤 | Hair growth agent composition |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009073806A (en) * | 2007-08-27 | 2009-04-09 | Iriya Cosmetics Co Ltd | Insulin-like growth factor-1 secretagogue |
| JP5948153B2 (en) * | 2012-06-06 | 2016-07-06 | ライオン株式会社 | Cosmetics-containing articles |
| WO2014006983A1 (en) * | 2012-07-05 | 2014-01-09 | ライオン株式会社 | Hair growing agent composition |
| WO2016102969A1 (en) * | 2014-12-23 | 2016-06-30 | The University Of Manchester | Inhibition of hair growth |
| JP6920116B2 (en) * | 2016-10-06 | 2021-08-18 | ライオン株式会社 | Hair restorer composition |
| WO2018074439A1 (en) * | 2016-10-18 | 2018-04-26 | 花王株式会社 | Cosmetic |
| US10555884B2 (en) | 2017-06-30 | 2020-02-11 | The Procter & Gamble Company | 2-pyridinol-N-oxide deodorant and antiperspirant compositions |
| MX2019015684A (en) | 2017-06-30 | 2020-02-26 | Procter & Gamble | Hair care compositions comprising a 2-pyridinol-n-oxide material and an iron chelator. |
| US10624828B2 (en) | 2017-06-30 | 2020-04-21 | The Procter & Gamble Company | Personal care compositions comprising a 2-pyridinol N-oxide material and an iron chelator |
| US10543164B2 (en) | 2017-06-30 | 2020-01-28 | The Procter & Gamble Company | Deodorant compositions |
| US11191705B2 (en) * | 2018-09-10 | 2021-12-07 | The Procter And Gamble Company | Personal cleansing compositions |
| KR102102578B1 (en) * | 2019-06-26 | 2020-04-21 | 코스맥스 주식회사 | Cosmetic composition for strengthening hair bulb comprising mixture of 18β-Glycyrrhetic acid, D-panthenol and Menthol as effective component |
| WO2021007587A1 (en) | 2019-07-05 | 2021-01-14 | The Procter & Gamble Company | Personal care cleaning compositions |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH1072321A (en) * | 1996-08-29 | 1998-03-17 | Sansho Seiyaku Co Ltd | Hair tonic |
| JPH10265343A (en) * | 1997-01-23 | 1998-10-06 | Taisho Pharmaceut Co Ltd | Long-acting hair restorer |
| JPH10218737A (en) * | 1997-02-10 | 1998-08-18 | Taisho Pharmaceut Co Ltd | Hair restorer |
-
2005
- 2005-12-26 JP JP2005371491A patent/JP2007169233A/en active Pending
-
2006
- 2006-12-26 KR KR1020060133679A patent/KR20070068288A/en not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20160021427A (en) * | 2013-05-15 | 2016-02-25 | 라이온 가부시키가이샤 | Hair growth agent composition |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007169233A (en) | 2007-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU597734B2 (en) | Sebum-dissolving nonaqueous minoxidil formulation | |
| EP2614815B1 (en) | Foamable aerosol composition | |
| KR20070068288A (en) | Parenting Composition | |
| WO2010125470A2 (en) | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof | |
| KR20080078795A (en) | Scalp Hair Cosmetic | |
| MX2010007410A (en) | Imiquimod formulation. | |
| CZ10295A3 (en) | Topic anti-inflammatory preparation based on piroxicam and method of solubilizing piroxicam | |
| KR20180020664A (en) | 2 component type cosmetic composition | |
| JPH11349451A (en) | Hair grower | |
| JP4796260B2 (en) | Minoxidil-containing preparation | |
| EP1671616B1 (en) | Hair growth promoter composition | |
| JP2004155690A (en) | Hair tonic composition | |
| KR950003611B1 (en) | Antimycotic external lmidazole preparations | |
| EP0221208A1 (en) | Hair growth promoting compositions | |
| JP2000198719A (en) | Hair growth agent | |
| KR20010089699A (en) | Spray-Type Cosmetic Composition And Matrix Used in Said Composition For Dermal Administration | |
| KR102050577B1 (en) | Stabilized cosmetic composition contain oil phase without surfactant | |
| EP4285931A1 (en) | Composition for external application | |
| EP3299012A1 (en) | Transdermal liquid preparation | |
| JP4060347B2 (en) | Oil-in-water emulsion lotion containing 22-oxa-1α, 25-dihydroxyvitamin D3 | |
| JP6503627B2 (en) | Pharmaceutical liquid composition | |
| WO2007086582A1 (en) | OIL-IN-WATER TYPE EMULSION LOTION CONTAINING 22-OXA-1α,25-DIHYDROXYVITAMIN D3 AND METHOD OF TREATING SKIN DISEASE BY USING THE SAME | |
| KR102752826B1 (en) | TRANSPARENT SOLUBILIZED COSMETIC COMPOSITION WITH HIGH CONTENT OF MENTHOL AND NON-MENTHOL COOLing agent | |
| US5078993A (en) | Ointment pharmaceutical formulation | |
| JP2006176447A (en) | Composition for scalp and hair |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20061226 |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |